Possible Interaction: Asymmetric Dimethylarginine and Olmesartan

“ ADMA levels were significantly lower in olmesartan treated group than in control group at T3, T4, T5 and T6 time points (p<0.05, p<0.05, p<0.05, p<0.01 respectively).”

“Conclusions: It was concluded that administration of olmesartan reduced plasma ADMA , SDMA, iNOS levels and enhanced L-arginine level in CPB time and it could reduce potential postoperative complications through reducing oxidative stress and inflammatory response in the postoperative period after coronary bypass surgery.”